MetaCap

F/m Emerald Life Sciences Innovation ETF (LFSC)

NASDAQ: LFSCEmerald Mutual Fund Advisers TrustHealthETFUSD

42.61+1.13 (+2.71%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

LFSC chart

Full chart

Key facts

Expense ratio
0.54%
Assets (AUM)
$123.35M
Dividend yield
—
Holdings
10
Inception
Oct 30, 2024
Issuer
Emerald Mutual Fund Advisers Trust
Index tracked
—
Category
Health
52-week range
29.44 – 48.78
Volume / Avg
559 / 3.69K
Beta
—
Previous close
41.48

LFSC ETF today

The F/m Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund from Emerald Mutual Fund Advisers Trust in the Health category. It charges an expense ratio of 0.54%, or $54.00 per year on a $10,000 investment, and manages $123.3 million in assets. Its largest holding is Corcept Therapeutics Inc (CORT) at 7.05% of assets, and the top 10 positions make up 52.1% of the portfolio out of 10 holdings.

LFSC launched on Oct 30, 2024.

Summary generated from market data by MetaCap's automated system. Methodology

LFSC top 10 holdings

LFSC holdings by weight
#HoldingWeight
1CORTCorcept Therapeutics Inc7.05%
2TVTXTravere Therapeutics Inc Ordinary Shares6.69%
3LIVNLivaNova PLC6.54%
4COGTCogent Biosciences Inc6.11%
5SYRESpyre Therapeutics Inc5.16%
6BLLNBillionToOne Inc Ordinary Shares - Class A4.67%
7GHGuardant Health Inc4.41%
8REPLReplimune Group Inc4.38%
9MANEVeradermics Inc3.64%
10MIRMMirum Pharmaceuticals Inc3.44%

Top 10 holdings: 52.1% of assets.

LFSC performance

1 week

+1.84%

LFSC price return, excluding dividends.

ETFs similar to LFSC

SPYState Street SPDR S&P 500 ETF Trust778.57 +0.60%VOOVanguard S&P 500 ETF715.59 +0.61%IVViShares Core S&P 500 ETF781.97 +0.60%RSPInvesco S&P 500 Equal Weight ETF213.04 +0.55%

LFSC ETF FAQ

What is the LFSC price today?

LFSC last traded at $42.61 as of Oct 9, 4:00 PM EDT, up 2.71% on the day.

What is LFSC's expense ratio?

LFSC has an expense ratio of 0.54%, which works out to about $54.00 per year for every $10,000 invested.

What are LFSC's top holdings?

LFSC's largest holdings are Corcept Therapeutics Inc (7.05%), Travere Therapeutics Inc Ordinary Shares (6.69%), LivaNova PLC (6.54%), Cogent Biosciences Inc (6.11%), Spyre Therapeutics Inc (5.16%). The top 10 make up 52.1% of the fund.

How big is LFSC?

LFSC has about $123.3 million in assets under management spread across 10 holdings.

Explore